Skip to main content
. 2016 Nov 22;5:37468. doi: 10.1038/srep37468

Figure 7. BCH ameliorated HF/HFr-induced hyperglycemia in C57BL/6J mice.

Figure 7

(a) Blood glucose after fasting for 6 h was measured using an Accu-Check glucometer. (b) Hepatic glucose production (HGP) was determined during hyperinsulinemic–euglycemic clamps. (c) Intraperitoneal glucose tolerance test (IPGTT) was carried out by measuring glucose levels at 0, 0.5, 1, and 2 h after glucose injection (1 g/kg). (d) Plasma insulin level after fasting for 6 h was measured using an insulin radioimmunoassay (RIA) kit. (e) Intraperitoneal insulin tolerance test (IPITT) was carried out by measuring glucose levels at 0, 0.5, 1, and 2 h after insulin injection (0.5 U/kg). (f) Glucose infusion rates were measured during hyperinsulinemic–euglycemic clamps. Data were represented as means ± SEM of three independent experiments (n = 10 per group). *p < 0.05, **p < 0.01 vs. BCH-untreated Hf/Hfr group.